Unknown

Dataset Information

Talimogene laherparepvec in combination with pembrolizumab leads to a complete response in a patient with refractory Merkel cell carcinoma.


ABSTRACT:

SUBMITTER: Lara KM 

PROVIDER: S-EPMC6226586 | biostudies-literature | 2018 Nov

REPOSITORIES: biostudies-literature